Crowdonomics
All companies

Quara Devices Inc.

Operating

Healthcare · Boulder, CO

Estimated pre-money ⓘ
$223.1M
As of May 2020 · from Reg A Offering (2020) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$2,033
Crowd $0 · Private $2K · 2 rounds since 2019
Latest share price
$5.80
Reg A Offering (2020) offering price

Financials

FY2019–FY2020 · from SEC filings · hover any figure for its source
$0
−$912K
2019
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 audited
FY2020 audited
Income statement
Revenue
$0
—
Cost of goods sold
$0
—
Net income
-$911,927
—
Balance sheet
Cash
$360,359
$22,411
Accounts receivable
$50,000
—
Total assets
$430,359
—
Long-term debt
$0
—
Total liabilities
$440,250
—
Other
Headcount
1
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$223.1M
est. pre-money
Reg A+ · Equity · May 2020

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Dec 31, 2020
ClassOutstandingVotes / shareShare of totalLast price
Common Stock38,457,361—100.0%—

Shares outstanding over timein today's share terms

38M19M0
Dec 2019May 2020
Common Stock

Principal holders% as the filing states it, Sep 1, 2020

  • Michael B. Harrison Director2,561,618 Common Stock7.1%of company
  • Yu-Cheng1,000,000 Common Stock3.1%of company
  • Nicolette A. Keith Chief Financial Officer740,000 Common Stock2.7%of company
  • Kenneth F. Reardon600,000 Common Stock2.3%of company
  • Larry K. Doan Director500,000 Common Stock1.8%of company
  • Cynthia Ekberg Tsai Director200,000 Common Stock0.5%of company

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg A+ · Equity · May 2020Closedvia DALMORE GROUP LLC
Raised $0 / $17.9MEst. pre-money $223.1M
Raised $2KInvestors 51

Team

8 people
Steven C. Eror
Chief Executive Officer
Kenneth F. Reardon
Chief Science Officer
Nicolette A. Keith
Chief Financial Officer
Yu-Cheng (Mike) Kao
Vice President, Finance
David W. Smalley
General Counsel
Rodney W. Reum
Executive Chairman
Larry K. Doan
Director
Michael B. Harrison
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 1-A-WSep 24, 20210001493152-21-023552
    EDGAR
  • Form 1-ZSep 24, 20210001493152-21-023554
    EDGAR
  • Form 1-UJul 7, 20210001493152-21-016293
    EDGAR
  • Form 1-UJun 30, 20210001493152-21-015633
    EDGAR
  • Form 1-KApr 30, 20210001493152-21-010090
    EDGAR
  • Form 1-UDec 30, 20200001493152-20-024607
    EDGAR
  • Form 1-SADec 22, 20200001493152-20-024072
    EDGAR
  • Form 1-UDec 7, 20200001493152-20-023027
    EDGAR
Source: SEC EDGARCIK 0001770427WYShare price $5.80Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.